CTOs on the Move

Impel NeuroPharma

www.impelneuropharma.com

 
Impel NeuroPharma is a Seattle-based company developing intranasal drug treatments for central nervous system (CNS) disorders. Impel has developed a novel drug delivery platform, the POD technology, that administers drug to the deep nasal cavity to improve the brain distribution of many drugs. Impel`s proprietary (POD) device technology enables entirely new categories of drugs, including biologics, to be delivered to the central nervous system using a cost-effective, disposable, non-invasive intranasal drug delivery device.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Impel NeuroPharma raised $36M on 12/02/2016
Impel NeuroPharma raised $67.5M on 12/06/2018

Similar Companies

Unified Healthcare

Unified Healthcare is a Santa Fe Springs, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

EnClear Therapies

At Enclear Therapies, our mission is to halt the progression of disease and extend the lives of patients with Amyotrophic Lateral Sclerosis (ALS) and Progressive Supranuclear Palsy (PSP) by removing toxic proteins that build up in the brain, significantly impacting neurodegeneration.

Visage imaging

Visage imaging is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Montvale Technologies

Montvale Technologies is a Montvale, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Noctrix Health

Noctrix Health is a pioneer in developing the next-generation of wearable therapeutics. Backed by scientific evidence and clinical data, we aim to make prescription-grade medical devices accessible so physicians and patients have more choices beyond the pill. Stay tuned for updates.